Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
March 14, 2019
C4 Therapeutics Appoints Adam Crystal, M.D., Ph.D. as Chief Medical Officer
READ MORE
February 20, 2019
WUGEN Presents New Data for Key CAR-T Platform at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR
READ MORE
January 04, 2019
Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions
READ MORE
January 04, 2019
C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-Based Medicines with Roche
READ MORE
December 03, 2018
WUGEN Presents Updated Preclinical Data on Novel Allogeneic CAR-T Platform at ASH Annual Meeting
READ MORE
November 01, 2018
WUGEN Announces Presentations at American Society of Hematology Annual Meeting
READ MORE
May 03, 2018
C4 Therapeutics Announces Appointment of Andrew Phillips, Ph.D. as President and Chief Executive Officer
READ MORE
May 03, 2018
C4 Therapeutics Announces Promotion of Stewart Fisher, Ph.D. to Chief Scientific Officer
READ MORE
March 26, 2018
C4 Therapeutics Announces Publication in Nature Chemical Biology on Degradation Technologies Licensed from Dana-Farber Cancer Institute
READ MORE
1
18
19
20
21
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2021 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group